Flavoxate hydrochloride at a daily dosage of 600 mg was compared to a daily dosage of 1200 mg for the treatment of unstable bladder. Twenty-seven patients were treated for 4 weeks in a double-blind, randomized, parallel-group trial. Clinically, both schedules were equally successful. In urodynamic terms, however, particularly with respect to uninhibited detrusor contractions, 1200 mg/day was significantly superior to 600 mg/day. Tolerability was excellent for both regimens. The side-effect free treatment of urgency and urge incontinence is of paramount importance for a patient's quality of life.

Milani, R., Scalambrino, S., Carrera, S., Pezzoli, P., Ruffmann, R. (1988). Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 16(3), 244-248 [10.1177/030006058801600313].

Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence

MILANI, RODOLFO;
1988

Abstract

Flavoxate hydrochloride at a daily dosage of 600 mg was compared to a daily dosage of 1200 mg for the treatment of unstable bladder. Twenty-seven patients were treated for 4 weeks in a double-blind, randomized, parallel-group trial. Clinically, both schedules were equally successful. In urodynamic terms, however, particularly with respect to uninhibited detrusor contractions, 1200 mg/day was significantly superior to 600 mg/day. Tolerability was excellent for both regimens. The side-effect free treatment of urgency and urge incontinence is of paramount importance for a patient's quality of life.
Articolo in rivista - Articolo scientifico
Flavonoids; Drug Administration Schedule; Humans; Urinary Bladder Diseases; Adult; Clinical Trials as Topic; Muscle Contraction; Flavoxate; Adolescent; Urinary Bladder; Female
English
1988
16
3
244
248
none
Milani, R., Scalambrino, S., Carrera, S., Pezzoli, P., Ruffmann, R. (1988). Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 16(3), 244-248 [10.1177/030006058801600313].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/35905
Citazioni
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 11
Social impact